2016 RESEARCH

- Archives -

NIH study builds on previous UMMS research into chemoresistance in breast, ovarian cancer

NIH study builds on previous UMMS research into chemoresistance in breast, ovarian cancer

A new NIH study published in Nature, based on research by Sharon Cantor, PhD, helps scientists better understand how hereditary breast and ovarian cancer genes function in the repair of broken DNA. Members of Dr. Cantor’s lab contributed to the study.

Dekker, colleagues at Curie Institute untangle Barr body of inactive X chromosome

Dekker, colleagues at Curie Institute untangle Barr body of inactive X chromosome

Job Dekker, PhD, and scientists at Institut Curie in Paris and Stanford University have taken a detailed look inside the small, densely packed structure of the inactive X chromosome found in female mammals called the Barr body.

Third Rock Ventures launches Fulcrum Therapeutics; Michael Green of UMMS a co-founder

Third Rock Ventures launches Fulcrum Therapeutics; Michael Green of UMMS a co-founder

Michael Green, MD, PhD, is one of five scientific co-founders of Fulcrum Therapeutics, a new company located in Cambridge’s Kendall Square focused on discovering and developing small molecules that modulate the on/off control mechanisms that regulate genes.

Kamber Kaya and Hall representing women in science at The Allied Genetics Conference

Kamber Kaya and Hall representing women in science at The Allied Genetics Conference

GSBS student Hatem Elif Kamber Kaya was honored to have two speaking engagements at The Allied Genetics Conference, the annual national meeting of the Genetics Society of America. 

UMMS researchers discover novel link between immune system, social behavior

UMMS researchers discover novel link between immune system, social behavior

Vladimir Litvak, PhD, and colleagues made a startling discovery that immune system signaling can directly affect social behavior. Published in Nature, these findings could have great implications for neurological diseases such as autism-spectrum disorders and schizophrenia.

Meyers Primary Care Institute celebrates 20 years

Meyers Primary Care Institute celebrates 20 years

For 20 years the Meyers Primary Care Institute—a unique partnership between UMass Medical School, Fallon Health and Reliant Medical Group—has quietly improved population health through research and education.

Long noncoding RNA found to quell inflammation

Long noncoding RNA found to quell inflammation

A long noncoding RNA (lincRNA)—called lincRNA-EPS—responsible for regulating innate immunity has been identified by a team of scientists at UMass Medical School. The findings were published in Cell. Katherine A. Fitzgerald, PhD, professor of medicine, is senior author on the study.

UMMS instructor studying link between protein in type 2 diabetes, cardiovascular diseases

UMMS instructor studying link between protein in type 2 diabetes, cardiovascular diseases

Shashi Kant, PhD, instructor of medicine, has received a $231,000 Scientist Development Grant from the American Heart Association to study a specific protein that could be the link between type 2 diabetes and atherosclerosis.

Peter Chai on CNBC explains how Google Glass can aid emergency patients

Peter Chai on CNBC explains how Google Glass can aid emergency patients

Peter R. Chai, MD, assistant professor of emergency medicine, discussed his research using Google Glass in the emergency department in a CNBC “The Spark” interview.

Stephen Miller receives McKnight Technological Innovations in Neuroscience Award

Stephen Miller receives McKnight Technological Innovations in Neuroscience Award

Stephen C. Miller, PhD, associate professor of biochemistry & molecular pharmacology, received a 2016 McKnight Technological Innovations in Neuroscience Award for his work overcoming barriers to imaging in the brain.

Showing 1-10 of 76 items
of 8

Stay Connected with UMassMedNow

▴ Back To Top
Section Menu To Top